These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21494698)
41. Pneumococcal vaccination in adults: does it really work? Pitsiou GG; Kioumis IP Respir Med; 2011 Dec; 105(12):1776-83. PubMed ID: 21816596 [TBL] [Abstract][Full Text] [Related]
42. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). Oosterhuis-Kafeja F; Beutels P; Van Damme P Vaccine; 2007 Mar; 25(12):2194-212. PubMed ID: 17267077 [TBL] [Abstract][Full Text] [Related]
43. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773 [TBL] [Abstract][Full Text] [Related]
44. Pneumococcal Mastoiditis in Children Before and After the Introduction of Conjugate Pneumococcal Vaccines. Koutouzis EI; Michos A; Koutouzi FI; Chatzichristou P; Parpounas K; Georgaki A; Theodoridou M; Tsakris A; Syriopoulou VP Pediatr Infect Dis J; 2016 Mar; 35(3):292-6. PubMed ID: 26569193 [TBL] [Abstract][Full Text] [Related]
45. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model. Skinner JM; Indrawati L; Cannon J; Blue J; Winters M; Macnair J; Pujar N; Manger W; Zhang Y; Antonello J; Shiver J; Caulfield M; Heinrichs JH Vaccine; 2011 Nov; 29(48):8870-6. PubMed ID: 21964055 [TBL] [Abstract][Full Text] [Related]
46. Vaccines for other neonatal infections: pneumococcal disease: a major global health problem of young children. Richmond P Expert Rev Vaccines; 2004 Aug; 3(4):379-82. PubMed ID: 15270639 [TBL] [Abstract][Full Text] [Related]
47. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824 [TBL] [Abstract][Full Text] [Related]
48. Recent approaches in vaccine development against Streptococcus pneumoniae. Tarahomjoo S J Mol Microbiol Biotechnol; 2014; 24(4):215-27. PubMed ID: 25196525 [TBL] [Abstract][Full Text] [Related]
50. Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany. Kieninger DM; Kueper K; Steul K; Juergens C; Ahlers N; Baker S; Jansen KU; Devlin C; Gruber WC; Emini EA; Scott DA; Vaccine; 2010 Jun; 28(25):4192-203. PubMed ID: 20417262 [TBL] [Abstract][Full Text] [Related]
51. Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Borrow R; Heath PT; Siegrist CA Curr Opin Infect Dis; 2012 Jun; 25(3):292-303. PubMed ID: 22517603 [TBL] [Abstract][Full Text] [Related]
52. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740]. Rodgers GL; Arguedas A; Cohen R; Dagan R Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215 [No Abstract] [Full Text] [Related]
53. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845 [TBL] [Abstract][Full Text] [Related]
54. How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better? Lu CY; Huang LM J Formos Med Assoc; 2011 Feb; 110(2):67-9. PubMed ID: 21377059 [No Abstract] [Full Text] [Related]
55. Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults. Peñaranda M; Payeras A; Cambra A; Mila J; Riera M; AIDS; 2010 May; 24(8):1226-8. PubMed ID: 20299956 [TBL] [Abstract][Full Text] [Related]
56. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785 [TBL] [Abstract][Full Text] [Related]
57. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine. Yildirim I; Shea KM; Pelton SI Infect Dis Clin North Am; 2015 Dec; 29(4):679-97. PubMed ID: 26610421 [TBL] [Abstract][Full Text] [Related]
58. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Prymula R Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951 [TBL] [Abstract][Full Text] [Related]